Richard Klausner - Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LYEL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard Klausner - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Richard Klausner for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.97M $1.39M $0.47 May 15, 2025 Direct
Common Stock 843K $396K $0.47 May 15, 2025 Grantor and Trustee
Option (right to buy) 130K May 15, 2025 Direct Common Stock
Option (right to buy) 130K Jun 14, 2024 Direct Common Stock

Transactions reported by Richard Klausner for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.